METHODS: We report a A 60-year-old female patient with FTMH secondary to branched retinal vein occlusion (BRVO) initially associated with ERP.
METHODS: She was successfully managed by treating with combination of intravitreal injection of off label bevacizumab (Avastin) (1.25 mg/0.05 ml) and pure gas of SF6 (1 cc) under topical anaesthesia after an initial surgical intervention.
CONCLUSIONS: Presence of ERP in retinal vein occlusion cases needs closer and frequent follow up. IVB can be used as an adjunct in treating secondary MH.
方法:我们报告了一名60岁的女性FTMH患者,继发于视网膜分支静脉阻塞(BRVO),最初与ERP相关。
方法:在初次手术干预后,在局部麻醉下,玻璃体内注射脱标贝伐单抗(阿瓦斯汀)(1.25mg/0.05ml)和SF6纯气体(1cc)联合治疗,成功治疗。
结论:视网膜静脉阻塞病例中存在ERP需要密切和频繁的随访。IVB可用作治疗继发性MH的辅助手段。